Matthew J. Zimpfer - 10 Feb 2026 Form 4 Insider Report for CNO Financial Group, Inc. (CNO)

Reporting relationship: General Counsel
Issuer ticker: CNO
Reported as of: 10 Feb 2026
Net transaction value: +$85,535
SEC form: 4
Accepted by SEC: 12 Feb 2026, 17:28:43 UTC
Prior SEC filing: 18 Nov 2025
Next SEC filing: 18 Feb 2026
Source filing: View source filing
Reporting owner signature: Heidi M. Krings, Attorney-in-Fact

Key filing fact

Matthew J. Zimpfer filed Form 4 for CNO Financial Group, Inc. (CNO) on 12 Feb 2026.

Key facts

This page summarizes Matthew J. Zimpfer's Form 4 filing for CNO Financial Group, Inc. (CNO).
6 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Feb 2026, 17:28.

Change

Previous filing in this sequence was filed on 18 Nov 2025.
Current net transaction value: +$85,535.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001438233 Primary reporting owner

Zimpfer Matthew J.

Relationship: General Counsel
Address: C/O CNO FINANCIAL GROUP, INC., 11299 ILLINOIS STREET, SUITE 200, CARMEL
Signature: Heidi M. Krings, Attorney-in-Fact
Signature date: 12 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNO transaction

Common Stock

Award

Transaction value: $1,092,781
Shares: +25,384
Change %: +9.2%
Price: $43.05
Shares after: 301,300
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F1

CNO transaction

Common Stock

Tax liability

Transaction value: $329,892
Shares: -7,663
Change %: -2.5%
Price: $43.05
Shares after: 293,637
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F2

CNO transaction

Restricted Stock Units

Award

Transaction value: $0
Shares: +14,300
Change %: +4.9%
Price: $0.000000
Shares after: 307,937
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F3, F4

CNO transaction

Common Stock

Options Exercise

Transaction value: $652,228
Shares: +30,970
Change %: +10%
Price: $21.06
Shares after: 338,907
Date: 12 Feb 2026
Ownership: Direct

CNO transaction

Common Stock

Sale

Transaction value: $1,329,582
Shares: -30,970
Change %: -9.1%
Price: $42.93
Shares after: 307,937
Date: 12 Feb 2026
Ownership: Direct
Footnotes: F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNO transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -30,970
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,970
Exercise price: $21.06
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Shares were acquired upon the vesting of performance share units for the 2023-2025 performance period, based on the issuer's (i) 2023 operating return on equity, (ii) 2023 operating earnings per share and (iii) three-year relative total shareholder return for 2023-2025.

Footnote F2

Shares were surrendered to the issuer to cover the required tax withholding on the vested performance share units.

Footnote F3

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F4

The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries.

Footnote F5

Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.

Footnote F6

Reflects the weighted average sale price. Shares were sold at prices ranging from $42.31 per share to $43.75 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

Footnote F7

One-half of the stock options vested on February 23, 2019, and one-half vested on February 23, 2020.